- Home
- TVAI vs BWAY Comparison
TVAI vs BWAY Comparison
Compare TVAI & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVAI
- BWAY
- Stock Information
- Founded
- TVAI 2024
- BWAY 2003
- Country
- TVAI United States
- BWAY Israel
- Employees
- TVAI N/A
- BWAY N/A
- Industry
- TVAI
- BWAY Medical/Dental Instruments
- Sector
- TVAI
- BWAY Health Care
- Exchange
- TVAI NYSE
- BWAY Nasdaq
- Market Cap
- TVAI 271.4M
- BWAY 245.2M
- IPO Year
- TVAI 2025
- BWAY 2019
- Fundamental
- Price
- TVAI $10.00
- BWAY $12.33
- Analyst Decision
- TVAI
- BWAY Strong Buy
- Analyst Count
- TVAI 0
- BWAY 2
- Target Price
- TVAI N/A
- BWAY $14.25
- AVG Volume (30 Days)
- TVAI 62.1K
- BWAY 49.1K
- Earning Date
- TVAI 01-01-0001
- BWAY 08-05-2025
- Dividend Yield
- TVAI N/A
- BWAY N/A
- EPS Growth
- TVAI N/A
- BWAY N/A
- EPS
- TVAI N/A
- BWAY 0.08
- Revenue
- TVAI N/A
- BWAY $43,457,000.00
- Revenue This Year
- TVAI N/A
- BWAY $351.53
- Revenue Next Year
- TVAI N/A
- BWAY $21.84
- P/E Ratio
- TVAI N/A
- BWAY $62.07
- Revenue Growth
- TVAI N/A
- BWAY 26.86
- 52 Week Low
- TVAI $10.02
- BWAY $5.98
- 52 Week High
- TVAI $10.18
- BWAY $13.66
- Technical
- Relative Strength Index (RSI)
- TVAI N/A
- BWAY 53.92
- Support Level
- TVAI N/A
- BWAY $12.76
- Resistance Level
- TVAI N/A
- BWAY $13.66
- Average True Range (ATR)
- TVAI 0.00
- BWAY 0.51
- MACD
- TVAI 0.00
- BWAY -0.09
- Stochastic Oscillator
- TVAI 0.00
- BWAY 51.51
About TVAI THAYER VENTURES ACQUISITION CORP II
Thayer Ventures Acquisition Corp II is a blank check company.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.